REIT - Office
Compare Stocks
4 / 10Stock Comparison
NYC vs AFCG vs REFI vs CMCT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Specialty
REIT - Mortgage
REIT - Office
NYC vs AFCG vs REFI vs CMCT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | REIT - Office | REIT - Specialty | REIT - Mortgage | REIT - Office |
| Market Cap | $20M | $73M | $245M | $6M |
| Revenue (TTM) | $39M | $6M | $44M | $117M |
| Net Income (TTM) | $-21M | $-20M | $4.87B | $-39M |
| Gross Margin | 6.2% | -76.6% | 95.6% | -10.3% |
| Operating Margin | -168.6% | -124.7% | 18.4% | 7.1% |
| Forward P/E | — | — | 6.4x | — |
| Total Debt | $403M | $76M | $98M | $510M |
| Cash & Equiv. | $10M | $39M | $15M | $15M |
NYC vs AFCG vs REFI vs CMCT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| American Strategic … (NYC) | 100 | 9.5 | -90.5% |
| Advanced Flower Cap… (AFCG) | 100 | 19.8 | -80.2% |
| Chicago Atlantic Re… (REFI) | 100 | 69.8 | -30.2% |
| Creative Media & Co… (CMCT) | 100 | 0.0 | -100.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NYC vs AFCG vs REFI vs CMCT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
In this particular matchup, NYC is outpaced on most metrics by others in the set.
AFCG plays a supporting role in this comparison — it may shine differently against other peers.
REFI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.69, yield 100.0%
- Rev growth 15.2%, EPS growth -10.6%, 3Y rev CAGR 8.9%
- 24.7% 10Y total return vs AFCG's -42.4%
- Lower volatility, beta 0.69, Low D/E 32.0%, current ratio 0.28x
CMCT lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% FFO/revenue growth vs AFCG's -39.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 109.7% margin vs AFCG's -333.9% | |
| Stability / Safety | Beta 0.69 vs AFCG's 1.86, lower leverage | |
| Dividends | 100.0% yield, 1-year raise streak, vs AFCG's 28.1%, (1 stock pays no dividend) | |
| Momentum (1Y) | -7.9% vs CMCT's -99.0% | |
| Efficiency (ROA) | 4.5% ROA vs AFCG's -6.4%, ROIC 6.9% vs -4.1% |
NYC vs AFCG vs REFI vs CMCT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
NYC vs AFCG vs REFI vs CMCT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
REFI leads in 4 of 6 categories
NYC leads 0 • AFCG leads 0 • CMCT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
REFI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CMCT is the larger business by revenue, generating $117M annually — 19.6x AFCG's $6M. REFI is the more profitable business, keeping 109.7% of every revenue dollar as net income compared to AFCG's -3.3%. On growth, AFCG holds the edge at +64.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $39M | $6M | $44M | $117M |
| EBITDAEarnings before interest/tax | -$53M | -$16M | $8M | $35M |
| Net IncomeAfter-tax profit | -$21M | -$20M | $4.9B | -$39M |
| Free Cash FlowCash after capex | -$13M | -$24M | $3.2B | -$15M |
| Gross MarginGross profit ÷ Revenue | +6.2% | -76.6% | +95.6% | -10.3% |
| Operating MarginEBIT ÷ Revenue | -168.6% | -124.7% | +18.4% | +7.1% |
| Net MarginNet income ÷ Revenue | -53.6% | -3.3% | +109.7% | -33.4% |
| FCF MarginFCF ÷ Revenue | -33.4% | -3.9% | +71.8% | -12.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +64.7% | -100.0% | +3.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | +16.7% | -51.1% | +97.5% |
Valuation Metrics
Evenly matched — REFI and CMCT each lead in 2 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, REFI's 9.1x EV/EBITDA is more attractive than CMCT's 14.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $20M | $73M | $245M | $6M |
| Enterprise ValueMkt cap + debt − cash | $413M | $110M | $328M | $500M |
| Trailing P/EPrice ÷ TTM EPS | -0.14x | -3.25x | 6.92x | -0.10x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 6.41x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 9.12x | 14.15x |
| Price / SalesMarket cap ÷ Revenue | 0.33x | 2.32x | 3.88x | 0.05x |
| Price / BookPrice ÷ Book value/share | 0.23x | 0.39x | 0.81x | 0.02x |
| Price / FCFMarket cap ÷ FCF | — | 6.47x | 0.01x | — |
Profitability & Efficiency
REFI leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
REFI delivers a 6.4% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-30 for NYC. REFI carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to NYC's 4.71x. On the Piotroski fundamental quality scale (0–9), REFI scores 5/9 vs CMCT's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -29.6% | -11.1% | +6.4% | -13.4% |
| ROA (TTM)Return on assets | -4.7% | -6.4% | +4.5% | -4.5% |
| ROICReturn on invested capital | -15.8% | -4.1% | +6.9% | +0.8% |
| ROCEReturn on capital employed | -20.8% | -5.6% | +9.3% | +1.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 5 | 2 |
| Debt / EquityFinancial leverage | 4.71x | 0.43x | 0.32x | 1.91x |
| Net DebtTotal debt minus cash | $393M | $38M | $83M | $494M |
| Cash & Equiv.Liquid assets | $10M | $39M | $15M | $15M |
| Total DebtShort + long-term debt | $403M | $76M | $98M | $510M |
| Interest CoverageEBIT ÷ Interest expense | -6.22x | -2.15x | 4.77x | 0.03x |
Total Returns (Dividends Reinvested)
REFI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in REFI five years ago would be worth $12,468 today (with dividends reinvested), compared to $402 for CMCT. Over the past 12 months, REFI leads with a -7.9% total return vs CMCT's -99.0%. The 3-year compound annual growth rate (CAGR) favors REFI at 7.9% vs CMCT's -65.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -6.0% | +10.2% | -1.4% | -98.1% |
| 1-Year ReturnPast 12 months | -30.7% | -35.5% | -7.9% | -99.0% |
| 3-Year ReturnCumulative with dividends | -6.0% | -20.1% | +25.7% | -95.9% |
| 5-Year ReturnCumulative with dividends | -88.1% | -44.6% | +24.7% | -96.0% |
| 10-Year ReturnCumulative with dividends | -93.8% | -42.4% | +24.7% | -59.4% |
| CAGR (3Y)Annualised 3-year return | -2.1% | -7.2% | +7.9% | -65.5% |
Risk & Volatility
Evenly matched — NYC and REFI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NYC is the less volatile stock with a -0.26 beta — it tends to amplify market swings less than AFCG's 1.86 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REFI currently trades 76.4% from its 52-week high vs CMCT's 0.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.26x | 1.86x | 0.69x | 1.20x |
| 52-Week HighHighest price in past year | $16.30 | $5.87 | $15.20 | $1441.00 |
| 52-Week LowLowest price in past year | $7.03 | $2.06 | $10.74 | $3.60 |
| % of 52W HighCurrent price vs 52-week peak | +49.6% | +52.6% | +76.4% | +0.5% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 48.2 | 58.1 | 21.2 |
| Avg Volume (50D)Average daily shares traded | 2K | 235K | 167K | 3.9M |
Analyst Outlook
REFI leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
For income investors, REFI offers the higher dividend yield at 100.00% vs AFCG's 28.10%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | — |
| Price TargetConsensus 12-month target | — | — | $14.00 | — |
| # AnalystsCovering analysts | — | — | 6 | — |
| Dividend YieldAnnual dividend ÷ price | — | +28.1% | +100.0% | +100.0% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $0.87 | $2045.71 | $23.89 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | 0.0% | 0.0% | +2.8% |
REFI leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
NYC vs AFCG vs REFI vs CMCT: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is NYC or AFCG or REFI or CMCT a better buy right now?
For growth investors, Chicago Atlantic Real Estate Finance, Inc.
(REFI) is the stronger pick with 15. 2% revenue growth year-over-year, versus -39. 6% for Advanced Flower Capital Inc. (AFCG). Chicago Atlantic Real Estate Finance, Inc. (REFI) offers the better valuation at 6. 9x trailing P/E (6. 4x forward), making it the more compelling value choice. Analysts rate Chicago Atlantic Real Estate Finance, Inc. (REFI) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — NYC or AFCG or REFI or CMCT?
Over the past 5 years, Chicago Atlantic Real Estate Finance, Inc.
(REFI) delivered a total return of +24. 7%, compared to -96. 0% for Creative Media & Community Trust Corporation (CMCT). Over 10 years, the gap is even starker: REFI returned +24. 7% versus NYC's -93. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — NYC or AFCG or REFI or CMCT?
By beta (market sensitivity over 5 years), American Strategic Investment Co.
(NYC) is the lower-risk stock at -0. 26β versus Advanced Flower Capital Inc. 's 1. 86β — meaning AFCG is approximately -803% more volatile than NYC relative to the S&P 500. On balance sheet safety, Chicago Atlantic Real Estate Finance, Inc. (REFI) carries a lower debt/equity ratio of 32% versus 5% for American Strategic Investment Co. — giving it more financial flexibility in a downturn.
04Which is growing faster — NYC or AFCG or REFI or CMCT?
By revenue growth (latest reported year), Chicago Atlantic Real Estate Finance, Inc.
(REFI) is pulling ahead at 15. 2% versus -39. 6% for Advanced Flower Capital Inc. (AFCG). On earnings-per-share growth, the picture is similar: Creative Media & Community Trust Corporation grew EPS 98. 4% year-over-year, compared to -218. 8% for Advanced Flower Capital Inc.. Over a 3-year CAGR, REFI leads at 8. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — NYC or AFCG or REFI or CMCT?
Chicago Atlantic Real Estate Finance, Inc.
(REFI) is the more profitable company, earning 57. 1% net margin versus -228. 3% for American Strategic Investment Co. — meaning it keeps 57. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: REFI leads at 57. 1% versus -196. 9% for NYC. At the gross margin level — before operating expenses — AFCG leads at 90. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — NYC or AFCG or REFI or CMCT?
In this comparison, REFI (100.
0% yield), CMCT (100. 0% yield), AFCG (28. 1% yield) pay a dividend. NYC does not pay a meaningful dividend and should not be held primarily for income.
07Is NYC or AFCG or REFI or CMCT better for a retirement portfolio?
For long-horizon retirement investors, American Strategic Investment Co.
(NYC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 26)). Advanced Flower Capital Inc. (AFCG) carries a higher beta of 1. 86 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NYC: -93. 8%, AFCG: -42. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between NYC and AFCG and REFI and CMCT?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NYC is a small-cap quality compounder stock; AFCG is a small-cap income-oriented stock; REFI is a small-cap high-growth stock; CMCT is a small-cap income-oriented stock. AFCG, REFI, CMCT pay a dividend while NYC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.